Ozempic Maker Novo Nordisk Downgraded to Sell After 70% Stock-Price Dive From Peak

3-line summary

• Novo Nordisk was downgraded to sell after a 70% stock-price dive from its peak, according to MarketWatch.
• Deutsche Bank issued the downgrade on Thursday.

This summary is our own processing of the source article; see the source link below for full context.